Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
742 participants
OBSERVATIONAL
2004-01-31
2005-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Registry
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients implanted with a new or replacement Marquis VR or Maximo VR ICD
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
George Klein, M.D.
Role: PRINCIPAL_INVESTIGATOR
London H.S.C. University Campus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham, Alabama, United States
Tuscaloosa, Alabama, United States
Little Rock, Arkansas, United States
Bakersfield, California, United States
Banning, California, United States
Fresno, California, United States
Mission Viejo, California, United States
Sacramento, California, United States
San Diego, California, United States
Stanford, California, United States
Littleton, Colorado, United States
Newark, Delaware, United States
Washington D.C., District of Columbia, United States
Jacksonville, Florida, United States
Lakeland, Florida, United States
Miami Beach, Florida, United States
Port Charlotte, Florida, United States
St. Petersburg, Florida, United States
Atlanta, Georgia, United States
Augusta, Georgia, United States
Decatur, Georgia, United States
Chicago, Illinois, United States
Hobart, Indiana, United States
Indianapolis, Indiana, United States
Cedar Rapids, Iowa, United States
Davenport, Iowa, United States
Kansas City, Kansas, United States
Lexington, Kentucky, United States
Owensboro, Kentucky, United States
Marrero, Louisiana, United States
Baltimore, Maryland, United States
Salisbury, Maryland, United States
Worcester, Massachusetts, United States
Ann Arbor, Michigan, United States
Saint Joseph, Michigan, United States
Southfield, Michigan, United States
Coon Rapids, Minnesota, United States
Saint Cloud, Minnesota, United States
Jackson, Mississippi, United States
Cape Girardeau, Missouri, United States
Joplin, Missouri, United States
Kansas City, Missouri, United States
St Louis, Missouri, United States
Missoula, Montana, United States
Las Vegas, Nevada, United States
Lebanon, New Hampshire, United States
Englewood, New Jersey, United States
Albany, New York, United States
Huntington, New York, United States
New Hyde Park, New York, United States
New York, New York, United States
Syracuse, New York, United States
Pinehurst, North Carolina, United States
Winston-Salem, North Carolina, United States
Cincinnati, Ohio, United States
Cleveland, Ohio, United States
Columbus, Ohio, United States
Mayfield Hts, Ohio, United States
Youngstown, Ohio, United States
Oklahoma City, Oklahoma, United States
Tulsa, Oklahoma, United States
Eugene, Oregon, United States
Portland, Oregon, United States
Allentown, Pennsylvania, United States
Hershey, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Spartanburg, South Carolina, United States
Chattanooga, Tennessee, United States
Knoxville, Tennessee, United States
Memphis, Tennessee, United States
Corpus Christi, Texas, United States
Dallas, Texas, United States
Fort Worth, Texas, United States
Houston, Texas, United States
Odessa, Texas, United States
Tyler, Texas, United States
Charlottesville, Virginia, United States
Richmond, Virginia, United States
Tacoma, Washington, United States
Milwaukee, Wisconsin, United States
Edmonton, Alberta, Canada
Victoria, British Columbia, Canada
St. John's, Newfoundland and Labrador, Canada
Halifax, Nova Scotia, Canada
Kingston, Ontario, Canada
London, Ontario, Canada
Ottawa, Ontario, Canada
Toronto, Ontario, Canada
Montreal, Quebec, Canada
Ste-Foy, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
232
Identifier Type: -
Identifier Source: org_study_id